EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimizing canine T cell activation, expansion, and transduction

Treyvon W Davis, Jennifer C Holmes, Arissa He, Paul R Hess iD, Christopher L Mariani, Yevgeny Brudno iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0324403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Treyvon W Davis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, College of Veterinary Medicine, North Carolina State University, North Carolina, Raleigh, United States of America. Hauptthemen laut MEDLINE: Lymphocyte Activation, T-Lymphocytes, Transduction, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dogs are becoming an important model for human cancers, and successfully troubleshooting issues with genetically modified T cell immunotherapy for round cell and solid neoplasms in dogs provides a unique opportunity to improve efficacy, safety, and affordability for humans as well. Unfortunately, T cell activation in dogs for optimal viral transduction has not been determined, restricting advancements in canine T cell immunotherapy. Two αCD3 and two αCD28 antibody clones for canine T cell stimulation have been described in the literature, but no studies have been undertaken to evaluate which αCD3/αCD28 combination is most effective, nor has anyone directly compared the efficacy of the two most popular antibody presentation strategies: antibody-coated plates and antibody-conjugated beads. In evaluating the effects of plate- or bead-bound αCD3 stimulation alone versus αCD3/αCD28 in combination, we tested 12 possible antibody stimulation strategies in addition to evaluating two largely unexplored mitogens in canine T cell transduction, phorbol myristate acetate (PMA) with ionomycin and concanavalin A (ConA). We investigated the impact of these stimulation strategies on canine T cell activation, expansion, and transduction. For stimulation strategies producing the best results, we also examined how each strategy affected the proportions of CD4/CD8 T cell subsets and regulatory T cell (T reg ) prevalence. We determined that, in general, plate-bound antibodies were far superior to bead-bound antibodies for canine T cell stimulation, and that plate-bound αCD3 clone CA17.6F9 in combination with αCD28 clone 5B8 or the mitogen PMA with ionomycin produced better activation and expansion profiles, better transduction, and more desirable T cell subsets that are more likely to improve patient outcomes in dogs suffering from round cell and solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocyte ActivationT-LymphocytesTransduction, GeneticAnimalsDogsIonomycinTetradecanoylphorbol AcetateCD3 ComplexCD28 AntigensCell Proliferation

Substanzen

IonomycinTetradecanoylphorbol AcetateCD3 ComplexCD28 Antigens

Autor:innen und Institutionen

  • Department of Biological Sciences, College of Veterinary Medicine, North Carolina State University, North Carolina, Raleigh, United States of America.
  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, North Carolina, Raleigh, United States of America.
  • College of Agriculture and Life Sciences, North Carolina State University, North Carolina, Raleigh, United States of America.
  • Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina, United States of America.
  • Comparative Medicine Institute, North Carolina State University, Raleigh, North Carolina, United States of America.

ORCID-Profile: Paul R Hess, Yevgeny Brudno

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Institutes of Health
  • Comparative Medicine Institute, North Carolina State University
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
  • North Carolina State University
  • North Carolina State University - GG Scholars
  • UNC Research

Zitieren

APA

Davis, T. W., Holmes, J. C., He, A., Hess, P. R., Mariani, C. L., & Brudno, Y. (2025). Optimizing canine T cell activation, expansion, and transduction. PLOS One. https://doi.org/10.1371/journal.pone.0324403

Vancouver

Davis TW, Holmes JC, He A, Hess PR, Mariani CL, Brudno Y. Optimizing canine T cell activation, expansion, and transduction. PLOS One. 2025. doi:10.1371/journal.pone.0324403

BibTeX
@article{Davis2025,
  author = {Davis, Treyvon W and Holmes, Jennifer C and He, Arissa and Hess, Paul R and Mariani, Christopher L and Brudno, Yevgeny},
  title = {Optimizing canine T cell activation, expansion, and transduction},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0324403}
}
Kostenlos starten →